Q/C Technologies, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value
Q/C Technologies, Inc. (QCLS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value of $4710.00 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue · last filed 2026-08-12
- Q/C Technologies, Inc. share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for the quarter ending 2026-03-31 was $4710.00, a 20289.61% increase year-over-year.
- Q/C Technologies, Inc. share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for the quarter ending 2025-03-31 was $23.10.
- Q/C Technologies, Inc. share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for the quarter ending 2019-03-31 was $22.40.
- Q/C Technologies, Inc. share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for fiscal 2025 was $2310.00, a 5730.39% increase from fiscal 2024.
- Q/C Technologies, Inc. share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for fiscal 2024 was $39.62.
- Q/C Technologies, Inc. share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for fiscal 2019 was $374.92, a 1604.18% increase from fiscal 2018.
- Q/C Technologies, Inc. share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for fiscal 2018 was $22.00, a 832.20% increase from fiscal 2017.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4710.00 10-Q · filed 2026-08-12 | |||
| 2026-03-31 | $4710.00 10-Q · filed 2026-05-15 | |||
| 2025-12-31 | $2310.00 10-K · filed 2026-04-15 | |||
| 2025-09-30 | $2310.00 10-Q · filed 2025-11-19 | |||
| 2025-06-30 | $23.10 10-Q · filed 2025-08-19 | |||
| 2025-03-31 | $23.10 10-Q · filed 2025-05-15 | |||
| 2024-12-31 | $39.62 10-K · filed 2025-04-11 | |||
| 2024-09-30 | $30.54 10-Q · filed 2024-11-14 | |||
| 2024-06-30 | $26.28 10-Q · filed 2024-08-19 | |||
| 2020-09-30 | $151.68 10-Q · filed 2020-11-16 | |||
| 2019-12-31 | $374.92 10-K · filed 2020-03-25 | |||
| 2019-09-30 | $18.51 10-Q · filed 2019-11-14 | |||
| 2019-06-30 | $23.72 10-Q · filed 2019-08-14 | |||
| 2019-03-31 | $22.40 10-Q · filed 2019-05-20 | |||
| 2018-12-31 | $22.00 10-K · filed 2019-04-01 | |||
| 2018-09-30 | $22.00 10-Q · filed 2018-11-14 | |||
| 2018-06-30 | $2.36 10-Q · filed 2018-08-14 | |||
| 2017-12-31 | $2.36 10-K/A · filed 2018-07-13 | |||
| 2017-09-30 | $2.36 10-Q/A · filed 2018-07-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |